This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 12 Nov 2018  |  Asia Pacific  |  Market Research

    Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021

    Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country

    Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

    $1,500.00
  2. 30 Oct 2018  |  Africa  |  Market Research

    Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018

    Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement

    The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...

    $1,500.00
  3. 23 Aug 2018  |  Europe  |  Market Research

    Western European Clinical Laboratory Services Market, Forecast to 2022

    Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support

    Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...

    $4,950.00
  4. 25 Jun 2018  |  Europe  |  Market Research

    Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022

    Rise in Cases of Sepsis and Antimicrobial Resistance (AMR) Along with the Focus on Preventative Care will Drive POCT Growth Throughout the Forecast Period

    The rise in infectious diseases across Europe has led to a growing need for early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is a vital part of the clinical diagnostics market and is rapidly evolving into the preferred testing mode as rapid infection diagnosis results in lower antibiotic intake, fewer...

    $1,500.00
  5. 10 Jan 2018  |  Asia Pacific  |  Mega Trends

    APAC Biosimilar Market, Forecast 2025

    Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

    Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...

    $4,950.00
  6. 30 Jun 2017  |  Europe  |  Mega Trends

    Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

    Data-driven Solutions and Co-development are Key Growth Drivers

    The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...

    $4,950.00
  7. 23 Jun 2017  |  Europe  |  Market Research

    Growth Opportunities in the Western European IVD Industry, Forecast to 2021

    Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

    Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...

    $4,950.00
  8. 22 Jun 2017  |  Asia Pacific  |  Market Research

    Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022

    Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia

    Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

    $1,500.00
  9. 19 Jun 2017  |  Asia Pacific  |  Mega Trends

    Growth Opportunities in the APAC IVD Market, Forecast to 2021

    Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market

    The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...

    $4,950.00
  10. 31 May 2017  |  Europe  |  Mega Trends

    Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021

    Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth

    The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...

    $4,950.00